PrEParing for Long-acting Technologies: A Multistate Analysis of PrEP Persistence and HIV and STI Lab Coverage Among Oral PrEP Initiators in St. Louis, Missouri (2014-2021)

为长效技术做好准备:密苏里州圣路易斯口服 PrEP 起始者的 PrEP 持续性及 HIV 和性传播感染实验室覆盖率的多州分析 (2014-2021)

阅读:4

Abstract

BACKGROUND: Engagement in pre-exposure prophylaxis (PrEP) care and routine screening for HIV and sexually transmitted infections (STIs) is critical to realizing the full benefits of this HIV prevention strategy. METHODS: We enrolled a cohort of individuals seeking PrEP services in two clinics in Missouri, an Ending the HIV Epidemic priority state, from June 2014 to November 2021. We used electronic health record and survey data to explore outcomes in the 2 years following linkage to care using multistate methods. We assessed transitions between eight mutually exclusive care states differentiated by receipt of a prescription, lab coverage status, and retention. We describe outcomes in the population overall and distinct sociodemographic subgroups. RESULTS: A total of 470 individuals were included (90.3% male; median age 29 (IQR, 25-36); 52.9% White, non-Hispanic) and contributed 879.5 person-years of follow-up. One week following linkage to care, 86.8% (95% CI: 83.6-90.0) of participants had a PrEP prescription. At month 6, 35.2% (95% CI: 30.7-39.7) were in care but had a lapse in HIV/STI screening, at month 12, 48.3% (95% CI: 43.7-53.1) were disengaged from care. Of those who disengaged, 28.3% (95% CI: 23.9-32.7) were re-engaged 6 months later. Females and uninsured individuals were the most likely to disengage during the first year of follow-up. CONCLUSIONS: Lapses in clinic visits and lab screening are common among PrEP users in Missouri and most who disengage do not return. Females, uninsured individuals, and other marginalized groups may be particularly susceptible to poor persistence suggesting targeted interventions are warranted.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。